Patent · US Active

Method for the treatment of multiple myeloma or non-Hodgkins lymphoma with anti-CD38 antibody and bortezomib or carfilzomib

US9765152B2 · kind B2 · utility

1Cited by

4References

14Claims

0Family size

Assignee

MORPHOSYS AG · DE

Inventors

Lisa Rojkjaer · Hedingen, CH
Rainer Boxhammer · Aying, DE
Jan Endell · Munich, DE
Mark Winderlich · Munich, DE
Christofer Samuelsson · Holzkirchen, DE

Key dates

Filing date	Feb 5, 2016
Grant date	Sep 19, 2017
Priority date	—
Expiry date	Feb 5, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method of treating multiple myeloma or non-hodgkins lymphoma with a pharmaceutical composition comprising an anti-CD38 antibody and bortezomib or carfilzomib is disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.